5-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)-3-methylbenzo[d]oxazol-2(3H)-one

Catalog No. :
ACBJFC396
CAS No. :
1802149-87-6
Molecular Formula :
C13H16BNO4
Molecular Weight :
261.09

IUPAC Name:5-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)-3-methylbenzo[d]oxazol-2(3H)-one

5-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)-3-methylbenzo[d]oxazol-2(3H)-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)-3-methylbenzo[d]oxazol-2(3H)-one
IUPAC Name5-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)-3-methylbenzo[d]oxazol-2(3H)-one
Molecular FormulaC13H16BNO4
Molecular Weight261.09
SMILESO=C1OC2=CC=C(B3OCC(C)(C)CO3)C=C2N1C
InChI KeyNQGFLCDEUIRVOD-UHFFFAOYSA-N
Synonym2(3H)-Benzoxazolone, 5-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)-3-methyl-;5-(5,5-Dimethyl-1,3,2-dioxaborinan-2-yl)-3-methyl-1,3-benzoxazol-2(3H)-one;5-(5,5-dimethyl-1,3,2-dioxaborinan-2-yl)-3-methylbenzo[d]oxazol-2(3H)-one
CAS No.1802149-87-6

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACBJFC396 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACDENL716 route compound structure diagram
    ACDENL71670672-82-1 In Stock
  4. Then
  5. ACBJFC396 route product structure diagram
    ACBJFC3961802149-87-6
Inquiry

2. ACBJFC396 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACBJFC396 route product structure diagram
    ACBJFC3961802149-87-6
Inquiry

Comments (0)